Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Non-invasive cardiac output monitor validation study in pediatric cardiac surgery patients.

Tirotta CF, Lagueruela RG, Madril D, Velis E, Ojito J, Monroe D, Aguero D, Irizarry M, McBride J, Hannan RL, Burke RP.

J Clin Anesth. 2017 May;38:129-132. doi: 10.1016/j.jclinane.2017.02.001. Epub 2017 Feb 12.

PMID:
28372651
2.

Seasonal Population Dynamics of Thrips (Thysanoptera) in Wisconsin and Iowa Soybean Fields.

Bloomingdale C, Irizarry MD, Groves RL, Mueller DS, Smith DL.

J Econ Entomol. 2017 Feb 1;110(1):133-141. doi: 10.1093/jee/tow242.

PMID:
28011679
3.

Development and validation of an algorithm for identifying urinary retention in a cohort of patients with epilepsy in a large US administrative claims database.

Quinlan SC, Cheng WY, Ishihara L, Irizarry MC, Holick CN, Duh MS.

Pharmacoepidemiol Drug Saf. 2016 Apr;25(4):413-21. doi: 10.1002/pds.3975. Epub 2016 Feb 17.

PMID:
26889887
4.

Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study.

Fitzpatrick AL, Irizarry MC, Cushman M, Jenny NS, Chi GC, Koro C.

Atherosclerosis. 2014 Aug;235(2):384-91. doi: 10.1016/j.atherosclerosis.2014.04.032. Epub 2014 May 22.

5.

Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetine.

Gooden KM, Bibeau KB, Wood J, Irizarry MC, Pan X, Allen J, Sampson T, Heim JM.

Curr Drug Saf. 2015;10(2):152-8.

PMID:
24861991
6.

Prevalence, risk factors, clinical consequences, and treatment of enteral feed intolerance during critical illness.

Gungabissoon U, Hacquoil K, Bains C, Irizarry M, Dukes G, Williamson R, Deane AM, Heyland DK.

JPEN J Parenter Enteral Nutr. 2015 May;39(4):441-8. doi: 10.1177/0148607114526450. Epub 2014 Mar 17.

PMID:
24637246
7.

Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study.

Davidson JE, Lockhart A, Amos L, Stirnadel-Farrant HA, Mooser V, Sollberger M, Regeniter A, Monsch AU, Irizarry MC.

Alzheimers Res Ther. 2012 Dec 7;4(6):51. doi: 10.1186/alzrt154. eCollection 2012.

8.

Sudden unexpected death in epilepsy in lamotrigine randomized-controlled trials.

Tomson T, Hirsch LJ, Friedman D, Bester N, Hammer A, Irizarry M, Ishihara L, Krishen A, Spaulding T, Wamil A, Leadbetter R.

Epilepsia. 2013 Jan;54(1):135-40. doi: 10.1111/j.1528-1167.2012.03689.x. Epub 2012 Oct 2.

9.

The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.

Yaffe K, Tocco M, Petersen RC, Sigler C, Burns LC, Cornelius C, Khachaturian AS, Irizarry MC, Carrillo MC.

Alzheimers Dement. 2012 May;8(3):237-42. doi: 10.1016/j.jalz.2011.12.005.

PMID:
22546356
10.

Incidence of new-onset seizures in mild to moderate Alzheimer disease.

Irizarry MC, Jin S, He F, Emond JA, Raman R, Thomas RG, Sano M, Quinn JF, Tariot PN, Galasko DR, Ishihara LS, Weil JG, Aisen PS.

Arch Neurol. 2012 Mar;69(3):368-72. doi: 10.1001/archneurol.2011.830.

11.

Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume.

Carmichael O, Xie J, Fletcher E, Singh B, DeCarli C; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2012 Jun;33(6):1124.e31-41. doi: 10.1016/j.neurobiolaging.2011.08.016. Epub 2011 Dec 14.

12.

Risk of cancer in patients exposed to gabapentin in two electronic medical record systems.

Irizarry MC, Webb DJ, Boudiaf N, Logie J, Habel LA, Udaltsova N, Friedman GD.

Pharmacoepidemiol Drug Saf. 2012 Feb;21(2):214-25. doi: 10.1002/pds.2266. Epub 2011 Dec 6.

13.

Background incidence of liver chemistry abnormalities in pediatric clinical trials for conditions with and without underlying liver disease.

Stirnadel HA, Bains C, Lakshmi M, Pandey R, Webb DJ, Irizarry MC, Hunt CM.

Regul Toxicol Pharmacol. 2012 Mar;62(2):329-35. doi: 10.1016/j.yrtph.2011.10.013. Epub 2011 Oct 28.

PMID:
22057095
14.

Detecting global and local hippocampal shape changes in Alzheimer's disease using statistical shape models.

Shen KK, Fripp J, Mériaudeau F, Chételat G, Salvado O, Bourgeat P; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2012 Feb 1;59(3):2155-66. doi: 10.1016/j.neuroimage.2011.10.014. Epub 2011 Oct 14.

PMID:
22037419
15.

Individual subject classification for Alzheimer's disease based on incremental learning using a spatial frequency representation of cortical thickness data.

Cho Y, Seong JK, Jeong Y, Shin SY; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2012 Feb 1;59(3):2217-30. doi: 10.1016/j.neuroimage.2011.09.085. Epub 2011 Oct 8.

PMID:
22008371
16.

BEaST: brain extraction based on nonlocal segmentation technique.

Eskildsen SF, Coupé P, Fonov V, Manjón JV, Leung KK, Guizard N, Wassef SN, Østergaard LR, Collins DL; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2012 Feb 1;59(3):2362-73. doi: 10.1016/j.neuroimage.2011.09.012. Epub 2011 Sep 16.

17.

Modeling Alzheimer's disease progression using the disease system analysis approach.

Gomeni R, Simeoni M, Zvartau-Hind M, Irizarry MC, Austin D, Gold M.

Alzheimers Dement. 2012 Jan;8(1):39-50. doi: 10.1016/j.jalz.2010.12.012. Epub 2011 Jul 22.

PMID:
21782528
18.

Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies.

Harrington C, Sawchak S, Chiang C, Davies J, Donovan C, Saunders AM, Irizarry M, Jeter B, Zvartau-Hind M, van Dyck CH, Gold M.

Curr Alzheimer Res. 2011 Aug;8(5):592-606.

PMID:
21592048
19.

Risk factors for antiepileptic drug regimen change in patients with newly diagnosed epilepsy.

Cunnington MC, Webb DJ, Irizarry MC, Manjunath R.

Epilepsy Behav. 2011 Jun;21(2):168-72. doi: 10.1016/j.yebeh.2011.03.017. Epub 2011 Apr 30.

PMID:
21531633
20.

Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis.

McEvoy LK, Holland D, Hagler DJ Jr, Fennema-Notestine C, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Radiology. 2011 Jun;259(3):834-43. doi: 10.1148/radiol.11101975. Epub 2011 Apr 6.

Supplemental Content

Loading ...
Support Center